High intensity focused ultrasound (HIFU) in the treatment of breast fibroadenomata: a feasibility study 
Methods
Patients (age ≥18 years) were recruited with symptomatic fibroadenomata which had to be visible on US (grade U2/U3). In patients older than 25 years, a fine needle aspiration cytology (FNAC) or core needle biopsy (CNB) was performed to confirm the diagnosis of a FAD. Patients were treated using the US guided -THone Echopulse device (Theraclion, France) under local anaesthesia (1:1, 1% Lignocaine with adrenaline and 0.25-0.50% Chirocaine).
Results and conclusions
From December 2013, 13 patients with symptomatic fibroadenomata underwent circumferential HIFU treatment. Seven patients opted for HIFU treatment due to pain or discomfort. Average treatment time for approximately 61 sonications (SD, 17 sonications), was 36 minutes (SD, 12 minutes). Circumferential treatment reduced treatment time by an average of 44% (SD, 21%). A two-sample T-test assuming unequal variances showed a significant reduction in treatment time (P = 0.005, two-tailed). Post-treatment follow-up at 2 weeks showed reduced pain in six out of seven patients with resolution of pain in three of these. An additional patient developed new pain after two weeks. Short-term complications were erythema of the skin (n=4), ecchymosis (n=4), temporarily numbness of the skin (n=1) and a first-degree skin burn (n=1).
Circumferential HIFU ablation of fibroadenomata is feasible with a significant reduction in treatment time.
